Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Novartis Changing Of The Guard Continues As R&D Chief Bradner Exits
Merck & Co’s Marshall To Take Over
Sep 01 2022
•
By
Andrew McConaghie
Bradner has headed up the Cambridge, MA-headquartered NIBR since 2016, but will hand over to Fiona Marshall in November. • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Immunological
More from Therapeutic Category